$5.50
+0.30 (+5.77%)
Open$5.26
Previous Close$5.20
Day High$5.53
Day Low$5.25
52W High$10.48
52W Low$3.53
Volume—
Avg Volume428.7K
Market Cap51.64M
P/E Ratio—
EPS$-2.92
SectorPharmaceuticals
Analyst Ratings
Strong Buy
9 analysts
Price Target
+47.6% upside
Current
$5.50
$5.50
Target
$8.12
$8.12
$6.66
$8.12 avg
$12.47
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 30.99M | 19.45M | 9.68M |
| Net Income | -12,949,798 | -7,313,515 | 2.71M |
| Profit Margin | -41.8% | -39.7% | 28.0% |
| EBITDA | -24,178,653 | -14,413,730 | 3.39M |
| Free Cash Flow | — | — | 1.90M |
| Rev Growth | +59.4% | +59.4% | +15.5% |
| Debt/Equity | — | — | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |